PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 4,660.00
-85.00 (-1.79%)
At close: Jul 31, 2025, 3:30 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 83.05 billion as of August 1, 2025. Its market cap has decreased by -12.10% in one year.
Market Cap
83.05B
Enterprise Value
88.40B
Revenue
171.66B
Ranking
n/a
PE Ratio
705.35
Stock Price
4,660.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 83.05B, an increase of 662.53%. That is a compound annual growth rate of 7.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 83.05B | 11.97% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | 165.78B | 123.51% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.15T |
| Celltrion | 39.70T |
| ALTEOGEN | 24.13T |
| Yuhan | 8,960.21B |
| SK Biopharmaceuticals | 7,815.66B |
| Peptron | 6,709.64B |
| HLB Co., Ltd. | 6,302.85B |
| PharmaResearch | 5,714.31B |